Viridian Therapeutics, Inc.\DE (VRDN) Shareholders’ equity 2016–2025
Viridian Therapeutics, Inc.\DE (VRDN) shareholders’ equity at each fiscal year-end, per SEC filings.
$722.2MFY2025 · since FY2016: -$61.9M → $722.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $722.2M | +7.5% |
| FY2024 | $671.6M | +51.9% |
| FY2023 | $442.0M | +11.9% |
| FY2022 | $395.1M | +110.5% |
| FY2021 | $187.7M | +56.4% |
| FY2020 | $120.0M | +661.9% |
| FY2019 | $15.8M | -69.3% |
| FY2018 | $51.3M | +33.3% |
| FY2017 | $38.5M | +162.2% |
| FY2016 | -$61.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice